Lithium Ion

Lithium Ion

SCHEMBL3695136

O=S(=O)([O-])c1cc(Cl)ccc1Cl.[Li+]

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 3/20 0.52
ALDH1A1 P00352 3/20 0.52
TSHR P16473 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
HPGD P15428 1/20 0.50
ALOX15 P16050 1/20 0.50
ACHE P22303 1/20 0.47
USP2 O75604 1/20 0.47
GAA P10253 1/20 0.46
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.45
TP53 P04637 2/20 0.44
AKR1B1 P15121 1/20 0.44
HTT P42858 2/20 0.43
NPSR1 Q6W5P4 1/20 0.43
MAPT P10636 1/20 0.42
MAPK1 P28482 1/20 0.42
PKM P14618 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11332440 0.98 MCL1 (0.53) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL31266402 0.98 MCL1 (0.53) MCL1ALDH1A1TSHRL3MBTL1HPGD
Potassium Ion SCHEMBL29653831 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL29653826 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL78761 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL5078513 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL31134735 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
Potassium Ion SCHEMBL3009008 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
SCHEMBL31134782 0.96 MCL1 (0.52) MCL1ALDH1A1TSHRL3MBTL1HPGD
Lithium Ion SCHEMBL3699048 0.83 S100A4 (0.46) MCL1ALDH1A1TSHRL3MBTL1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9079830-B2 Method for producing biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-14 US disclosed
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-05-17 US disclosed
US-4147545-A FOR DIAZO-SENSITIZED PHOTOSENSITIVE COATINGS POLYCHROME CORPORATION (US) 1979-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120123154-A1 METHOD FOR PRODUCING BIARYL COMPOUND AKR7A2, AOC2, CBR1 MCL1 393/4885ALDH1A1 35/4885TSHR 1160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.